EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Harnessing Gene Editing Technology for Tumor Microenvironment Modulation: An Emerging Anticancer Strategy

Shujun Feng iD, Yu Zhang, Yanyi Wang, Yanfeng Gao, Yujun Song iD

Chemistry – A European Journal · 07.11.2024 · 30 (62)

DOI: 10.1002/chem.202402485 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemistry – A European Journal, online erschienen am 16.10.2024. Verfasst von Shujun Feng und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Engineering and Applied Sciences, Nanjing University, 210023, Nanjing, China. Hauptthemen laut MEDLINE: Gene Editing, Tumor Microenvironment, CRISPR-Cas Systems, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 269 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Jiangsu Provincial Key Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is a multifaceted disease influenced by both intrinsic cellular traits and extrinsic factors, with the tumor microenvironment (TME) being crucial for cancer progression. To satisfy their high proliferation and aggressiveness, cancer cells always plunder large amounts of nutrients and release various signals to their surroundings, forming a dynamic TME with special metabolic, immune, microbial and physical characteristics. Due to the neglect of interactions between tumor cells and the TME, traditional cancer therapies often struggle with challenges such as drug resistance, low efficacy, and recurrence. Importantly, the development of gene editing technologies, particularly the CRISPR‐Cas system, offers promising new strategies for cancer treatment. Combined with nanomaterial strategies, CRISPR‐Cas technology exhibits precision, affordability, and user‐friendliness with reduced side effects, which holds great promise for profoundly altering the TME at the genetic level, potentially leading to lasting anticancer outcomes. This review will delve into how CRISPR‐Cas can be leveraged to manipulate the TME, examining its potential as a transformative anticancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingTumor MicroenvironmentCRISPR-Cas SystemsNeoplasmsHumansAntineoplastic AgentsAnimals

Stichwörter der Autor:innen

CRISPR-CasDelivery systemGene editing technologyNanomaterialsTumor microenvironment

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • College of Engineering and Applied Sciences, Nanjing University, 210023, Nanjing, China.
  • School of Chemistry and Chemical Engineering, Nanjing University of Science and Technology, 210094, Nanjing, China.
  • School of Medical Imaging, Wannan Medical College, 241002, Wuhu, China.

ORCID-Profile: Shujun Feng, Yujun Song

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • Jiangsu Provincial Key Research and Development Program
  • Natural Science Foundation of Jiangsu Province
  • State Key Laboratory of Analytical Chemical for Life Science
  • Fundamental Research Funds for the Central Universities
  • National Key Research and Development Program of China

Zitieren

APA

Feng, S., Zhang, Y., Wang, Y., Gao, Y., & Song, Y. (2024). Harnessing Gene Editing Technology for Tumor Microenvironment Modulation: An Emerging Anticancer Strategy. Chemistry – A European Journal, 30(62). https://doi.org/10.1002/chem.202402485

Vancouver

Feng S, Zhang Y, Wang Y, Gao Y, Song Y. Harnessing Gene Editing Technology for Tumor Microenvironment Modulation: An Emerging Anticancer Strategy. Chemistry – A European Journal. 2024;30(62). doi:10.1002/chem.202402485

BibTeX
@article{Feng2024,
  author = {Feng, Shujun and Zhang, Yu and Wang, Yanyi and Gao, Yanfeng and Song, Yujun},
  title = {Harnessing Gene Editing Technology for Tumor Microenvironment Modulation: An Emerging Anticancer Strategy},
  journal = {Chemistry – A European Journal},
  year = {2024},
  volume = {30},
  number = {62},
  doi = {10.1002/chem.202402485}
}
Kostenlos starten →